Daratumumab/lenalidomide/dexamethasone in transplant-ineligible newly diagnosed myeloma: MAIA long-term outcomes
Facon T, et al.
Leukemia
February 2025
Authors and Affiliates
Thierry Facon1, Philippe Moreau 2, Katja Weisel 3, Hartmut Goldschmidt 4, Saad Z. Usmani 5, Ajai Chari6, Torben Plesner7,
Robert Z. Orlowski 8, Nizar Bahlis 9, Supratik Basu 10, Cyrille Hulin 11, Hang Quach 12, Michael O’Dwyer 13,
Aurore Perrot 14, Caroline Jacquet15, Christopher P. Venner16,17, Noopur Raje18, Mourad Tiab19, Margaret Macro20, Laurent Frenzel21,
Xavier Leleu 22, Gordon Cook 23, George Wang24, Huiling Pei25, Maria Krevvata24, Robin Carson24, Fredrik Borgsten26 and
Shaji K. Kumar
1University of Lille, CHU Lille, Service des Maladies du Sang, Lille, France. 2Hematology Department, University Hospital Hôtel-Dieu, Nantes, France. 3Department of Oncology,
Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. 4GMMG-Study Group at
University Hospital Heidelberg, Internal Medicine V, Heidelberg, Germany. 5Memorial Sloan Kettering Cancer Center, New York, NY, USA. 6Icahn School of Medicine at Mount
Sinai, New York, NY, USA. 7Vejle Hospital and University of Southern Denmark, Vejle, Denmark. 8Department of Lymphoma & Myeloma, The University of Texas MD Anderson
Cancer Center, Houston, TX, USA. 9Arnie Charbonneau Cancer Research Institute, University of Calgary, Calgary, AB, Canada. 10Royal Wolverhampton NHS Trust and University of
Wolverhampton, CRN West Midlands, NIHR, Wolverhampton, UK. 11Department of Hematology, Hôpital Haut Lévêque, University Hospital, Pessac, France. 12University of
Melbourne, St Vincent’s Hospital, Melbourne, VIC, Australia. 13Department of Medicine/Haematology, NUI, Galway, Republic of Ireland. 14CHU de Toulouse, IUCT-O, Université de
Toulouse, UPS, Service d’Hématologie, Toulouse, France. 15Department of Hematology, University Hospital, Nancy, France. 16Department of Medical Oncology, Cross Cancer
Institute, University of Alberta, Edmonton, AB, Canada. 17BC Cancer – Vancouver Centre Group, Vancouver, BC, Canada. 18Center for Multiple Myeloma, Massachusetts General
Hospital Cancer Center, Boston, MA, USA. 19CHD Vendée, La Roche sur Yon, France. 20Centre Hospitalier Universitaire (CHU) de Caen, Caen, France. 21Hôpital Necker-Enfants
Malades, Paris, France. 22CHU Poitiers, Hôpital la Milétrie, Poitiers, France. 23Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds,
Leeds, UK. 24Janssen Research & Development, LLC, Spring House, PA, USA. 25Janssen Research & Development, LLC, Titusville, NJ, USA. 26Janssen Research & Development, LLC,
Raritan, NJ, USA. 27Department of Hematology, Mayo Clinic Rochester, Rochester, MN, USA.